| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/31/2007 | CN1904034A Novel bacterium and vaccine |
| 01/31/2007 | CN1903881A Antitumour multitarget composite antigen, its coding gene and application |
| 01/31/2007 | CN1903879A Preparation method of high liter, high specificity anti human nerve nest protein monoclone antibody |
| 01/31/2007 | CN1903878A Anti SARS virus human source nature antibody IgG Fab section |
| 01/31/2007 | CN1903874A Preparation method of CYP1A2 polypeptide and antihuman CYP1A2 polypeptide antibody |
| 01/31/2007 | CN1297666C Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/30/2007 | US7170520 Display for sharing display data channel |
| 01/30/2007 | US7169908 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide |
| 01/30/2007 | US7169907 Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
| 01/30/2007 | US7169905 Modified peptides as therapeutic agents |
| 01/30/2007 | US7169904 Immunocytokine sequences and uses thereof |
| 01/30/2007 | US7169903 Killing gram positive bacteria in situ; vaccine |
| 01/30/2007 | US7169902 Collagen-binding proteins from Streptococcus pyogenes |
| 01/30/2007 | US7169901 Endothelial growth factors |
| 01/30/2007 | US7169898 Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 01/30/2007 | US7169897 Adipocyte complement related protein ZACRP3X2 |
| 01/30/2007 | US7169891 Human pellino polypeptides |
| 01/30/2007 | US7169751 combining a compound to be tested with a 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 polypeptide for binding of the test compound to the polypeptide; detecting binding for pain treatment |
| 01/30/2007 | US7169585 Papillomavirus vaccine |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | US7169567 Screening for an agonist or an antagonist of PTH receptor activity: |
| 01/30/2007 | US7169566 Metalloproteinases |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169398 Equine protozoal myeloencephalitis vaccine |
| 01/30/2007 | US7169393 Antigenic peptide fragments of VapA protein, and uses thereof |
| 01/30/2007 | US7169390 Administering an agent binds a sphingolipid or a sphingolipid metabolite, especially an antibody or derivative, a receptor of a sphingolipid or a sphingolipid metabolite. |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169388 unexpected discovery that the inhibition or antagonism of TNF decreases the expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF). VEGF has been implicated in the angiogenesis in cancer, vascular diseases and rheumatoid arthritis |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169386 Chimeric immunoglobulin; for the diagnosis and treatment of bacterail infection, cancer and septic shock |
| 01/30/2007 | CA2284859C Nucleic acid molecule for a human skeletal muscle-specific receptor |
| 01/30/2007 | CA2210751C Anti-cd6 monoclonal antibodies and their uses |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/25/2007 | WO2007011968A2 Beta-glucuronide-linker drug conjugates |
| 01/25/2007 | WO2007011941A2 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | WO2007011907A2 Alpha-synuclein antibodies and methods related thereto |
| 01/25/2007 | WO2007011873A2 Method for treating intraocular neovascular diseases |
| 01/25/2007 | WO2007011698A2 Humanized antibody conjugates and related methods, assays, reagents, and kits |
| 01/25/2007 | WO2007011680A2 Ligands to radiation-induced molecules |
| 01/25/2007 | WO2007011606A2 USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS |
| 01/25/2007 | WO2007011265A1 Method for blocking noggin2 target specific activities |
| 01/25/2007 | WO2007011091A1 Monoclonal antibody for hippuric acid antigen |
| 01/25/2007 | WO2007011041A1 Genetically modified antibody composition |
| 01/25/2007 | WO2007010999A1 Animal in which lipid metabolism and sugar metabolism are modified by krap gene mutation, modification method and modifying agent |
| 01/25/2007 | WO2007010941A1 Antigen and monoclonal antibody capable of recognizing the antigen |
| 01/25/2007 | WO2007010651A1 Novel proteins and method of using the same |
| 01/25/2007 | WO2007010586A1 Hematopoietic stem cell identifier |
| 01/25/2007 | WO2007010291A1 Vaccine |
| 01/25/2007 | WO2007010283A1 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein |
| 01/25/2007 | WO2007010231A1 Modified antibody fragments |
| 01/25/2007 | WO2007010040A1 Antigen binding polypeptides against f4 (k88) fimbriae |
| 01/25/2007 | WO2007009816A2 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | WO2006131951A3 MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT |
| 01/25/2007 | WO2006131013A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 01/25/2007 | WO2006130022A8 Modulation of ovulation by agonists and antagonists of bmprii |
| 01/25/2007 | WO2006128715A3 Polyclonal antiserum against a universal tumor antigen |
| 01/25/2007 | WO2006125200A3 Method for reducing sepsis or cardiogenic shock associated with myocardial injury |
| 01/25/2007 | WO2006122986A3 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 01/25/2007 | WO2006105219A3 T cell therapy for the treatment of cachexia and chronic diseases |
| 01/25/2007 | WO2006053125A3 Gp201: methods and compositions for treating cancer |
| 01/25/2007 | WO2006039238A3 Irta2 antibodies and methods of use |
| 01/25/2007 | WO2006031607A3 A method of treating cancer |
| 01/25/2007 | WO2005123128A3 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/25/2007 | WO2005118527A3 Fluorous capping reagents, and methods for peptide purification |
| 01/25/2007 | WO2005097998A3 Il-18 specific polypeptides and therapeutic uses thereof |
| 01/25/2007 | WO2004108065A3 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies |
| 01/25/2007 | WO2004058797A3 Human monoclonal antibodies against interleukin 8 (il-8) |
| 01/25/2007 | WO2004052186A3 Expressed genes that define the osteoclast phenotype |
| 01/25/2007 | US20070021599 Comprises transport proteins diagnosis and treatment of cell proliferative disorders; antiproliferative agents; gene expression inhibition; detecting differential methylation patterns in the SLC5A8 gene which encode novel sodium solute symporter members |
| 01/25/2007 | US20070021597 Expressed sequence tags (EST); nucleotide sequence encoding signal peptide; vectors |
| 01/25/2007 | US20070021596 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata, tick-borne infections such as rickettsiosis, filariasis, Q fever, African recurrent fever, or viral encephalitis |
| 01/25/2007 | US20070021595 Humanized antibody amd process for preparing same |
| 01/25/2007 | US20070021591 Compositions and methods for protein deaggregation |
| 01/25/2007 | US20070021364 Methods for genetic immunization |
| 01/25/2007 | US20070020746 Staphylococcus aureus polynucleotides and sequences |
| 01/25/2007 | US20070020733 Polypeptide for use in the diagnosis and detection of bacterial infections |
| 01/25/2007 | US20070020732 Inflammatory response protein for use in developing vaccines against allergic diseases; allergic response modulation; antiallergens; signal transducer specifically expressed in human mast cells |
| 01/25/2007 | US20070020730 Method for overexpression of zwitterionic polysaccharides |
| 01/25/2007 | US20070020725 Prokaryotically produced antibodies and uses thereof |
| 01/25/2007 | US20070020713 Antibodies to the fuel oxygenate mtbe and use thereof in immunoassays |
| 01/25/2007 | US20070020710 Antibodies that spefically recognize inactive PSA, and uses thereof |
| 01/25/2007 | US20070020708 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 01/25/2007 | US20070020706 Truncated proteins as cancer markers |
| 01/25/2007 | US20070020705 placental leucine aminopeptidase (P-LAP); cell surface aminopeptidase, oxytocinase, insulin-regulated membrane aminopeptidase associated with glucose transporter; ovarian cancer; polyclonaly antibodies |
| 01/25/2007 | US20070020695 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B' |
| 01/25/2007 | US20070020686 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 01/25/2007 | US20070020685 Secretion of antibodies without signal peptides from bacteria |
| 01/25/2007 | US20070020683 Monoclonal antibodies for detection of urinary trypsin inhibitors |
| 01/25/2007 | US20070020682 Use of prion conversion modulating agents |
| 01/25/2007 | US20070020678 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 01/25/2007 | US20070020290 Natural antibodieactive against HIV virus |
| 01/25/2007 | US20070020286 Recombinant constructs of Borrelia burgdorferi |
| 01/25/2007 | US20070020284 decreased protein degradation, increased stability and circulation time; for excess weight, diabetes, high blood lipid level, arteriosclerosis, arterial plaque, the reduction or prevention of gall stones formation, insufficient lean tissue mass, insufficient sensitivity to insulin, and stroke |
| 01/25/2007 | US20070020281 Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof |
| 01/25/2007 | US20070020280 Compositions and methods for inhibition of HIV-1 infection |
| 01/25/2007 | US20070020279 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody |
| 01/25/2007 | US20070020278 Diagnosing and treating cancer |
| 01/25/2007 | US20070020276 Methods for the treatment of carcinoma |
| 01/25/2007 | US20070020275 Nucleic acid sequences of hyperplasia and tumours of the thyroid |